Baseline and early on-treatment HBsAg level to predict HBsAg loss in nucleotide analog suppressed and HBeAg cleared chronic hepatitis B patients by switching to peginterferon alfa-2a: exploratory results of NEW SWITCH study

被引：0
|
作者：
Hu, P. [1 ]
Xie, Q. [2 ]
Li, Y. [3 ,11 ]
Chen, X. [4 ,19 ]
Dou, X. [5 ]
Jiang, J. [6 ,20 ]
Shang, J. [7 ]
Zhang, W. [8 ]
Gong, G. [9 ]
Sun, Y. [10 ]
Li, Y. [3 ,11 ]
Liu, Y. [12 ]
Liu, G. [13 ]
Mao, D. [14 ]
Chi, X. [15 ]
Tang, H. [16 ]
Li, X. [17 ]
Xie, Y. [18 ]
Chen, X. [4 ,19 ]
Jiang, J. [6 ,20 ]
Zhao, P. [21 ]
Hou, J. [22 ]
Gao, Z. [23 ]
Fan, H. [24 ]
Ding, J. [25 ]
Ren, H. [1 ]
机构：
[1] Chongqing Med Univ, Infect Dis, Affiliated Hosp 2, Chongqing, Peoples R China
[2] Shanghai Jiao Tong Univ, Infect Dis, Ruijin Hosp, Sch Med, Shanghai, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 1, Harbin, Peoples R China
[4] Capital Med Univ, Int Med Dept, Beijing YouAn Hosp, Beijing, Peoples R China
[5] China Med Univ, Shengjing Hosp, Infect Dis, Shenyang, Peoples R China
[6] Guangxi Med Univ, Affiliated Hosp 1, Infect Dis, Nanning, Peoples R China
[7] Henan Prov Peoples Hosp, Infect Dis, Zhengzhou, Peoples R China
[8] Fudan Univ, Huashan Hosp, Infect Dis, Shanghai, Peoples R China
[9] Cent S Univ, Xiangya Hosp 2, Infect Dis, Changsha, Hunan, Peoples R China
[10] Fourth Mil Med Univ, Infect Dis, Tangdu Hosp, Xian, Peoples R China
[11] Ningxia Med Univ, Infect Dis, Gen Hosp, Yinchuan, Peoples R China
[12] Shenzhen Third Peoples Hosp, Liver Dis Dept, Shenzhen, Peoples R China
[13] Cent S Univ, Infect Dis, Xiangya Hosp, Changsha, Hunan, Peoples R China
[14] Guangxi Univ Chinese Med, Liver Dis Dept, Affiliated Hosp 1, Nanning, Peoples R China
[15] Guangdong Hosp Tradit Chinese Med, Liver Dis Dept, Guangzhou, Guangdong, Peoples R China
[16] Sichuan Univ, Infect Dis, West China Hosp, Chengdu, Peoples R China
[17] Sixth Peoples Hosp Hangzhou, Liver Dis Dept, Hangzhou, Zhejiang, Peoples R China
[18] Capital Med Univ, Beijing Ditan Hosp, Liver Dis Dept, Beijing, Peoples R China
[19] Guangdong Gen Hosp, Infect Dis, Guangzhou, Guangdong, Peoples R China
[20] Fujian Med Univ, Affiliated Hosp 1, Liver Dis Dept, Fuzhou, Peoples R China
[21] 302 Hosp PLA, Int Ctr Liver Dis Treatment, Beijing, Peoples R China
[22] Southern Med Univ, Nanfang Hosp, Infect Dis, Guangzhou, Guangdong, Peoples R China
[23] Sun Yat Sen Univ, Affiliated Hosp 3, Infect Dis, Guangzhou, Guangdong, Peoples R China
[24] Guangzhou Eighth Peoples Hosp, Hepatol Unit, Guangzhou, Guangdong, Peoples R China
[25] Ruian Peoples Hosp, Hepatol Unit, Ruian, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)30842-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-175
引用
收藏
页码：S265 / S265
页数：1
相关论文
共 50 条
  • [31] A NOVEL COMBINATION REGIMEN OF PEGINTERFERON ALFA-2A AND ENTECAVIR RESULTS IN SUSTAINED POST-TREATMENT HBSAG CLEARANCE IN HBEAG-POSITIVE CHRONIC HEPATITIS B (CHB)
    Sheng, Jifang
    Bai, Xuefan
    Wu, Shuhuan
    Chen, Jianjie
    Sheng, Jifang
    Xie, Yao
    Chen, Chengwei
    Jiang, Michael
    Xie, Ding
    HEPATOLOGY, 2011, 54 : 1017A - 1017A
  • [32] The Predictive Value of Baseline HBsAg Level and Early Response for HBsAg Loss in Patients with HBeAg-positive Chronic Hepatitis B during Pegylated Interferon Alpha-2a Treatment
    LI Ming Hui
    ZHANG Lu
    QU Xiao Jing
    LU Yao
    SHEN Ge
    LI Zhen Zhen
    WU Shu Ling
    LIU Ru Yu
    CHANG Min
    HU Lei Ping
    HUA Wen Hao
    SONG Shu Jing
    WAN Gang
    XIE Yao
    Biomedical and Environmental Sciences, 2017, 30 (03) : 177 - 184
  • [33] The Predictive Value of Baseline HBsAg Level and Early Response for HBsAg Loss in Patients with HBeAg-positive Chronic Hepatitis B during Pegylated Interferon Alpha-2a Treatment
    Li Ming Hui
    Zhang Lu
    Qu Xiao Jing
    Lu Yao
    Shen Ge
    Li Then Zhen
    Wu Shu Ling
    Liu Ru Yu
    Chang Min
    Hu Lei Ping
    Hua Wen Hao
    Song Shu Jing
    Wan Gang
    Xie Yao
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2017, 30 (03) : 177 - 184
  • [34] HIGH LEVELS OF HBSAG AND HBV DNA DURING TREATMENT PREDICT FAILURE FOR HBEAG SEROCONVERSION IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEGASYS®) AND ADEFOVIR (HEPSERA); AN INTERIM ANALYSIS
    Takkenberg, Bart
    Zaaijer, Hans L.
    de Niet, Annikki
    Weegink, Christine J.
    Terpstra, Valeska
    Koot, Maarten
    Dijkgraaf, Marcel
    Jansen, Peter L.
    Janssen, Harry L.
    Beld, Marcel
    Reesink, Hendrik W.
    HEPATOLOGY, 2009, 50 (04) : 541A - 541A
  • [35] ADD-ON PEGINTERFERON ALFA-2A SIGNIFICANTLY REDUCES HBSAG LEVELS IN HBEAG-NEGATIVE, GENOTYPE D CHRONIC HEPATITIS B PATIENTS FULLY SUPPRESSED ON NUCLEOT(S)IDE ANALOGUES TREATMENT: FINAL RESULTS OF THE HERMES STUDY
    Lampertico, P.
    Brunetto, M. R.
    Craxi, A.
    Gaeta, G. B.
    Rizzetto, M.
    Rozzi, A.
    Colombo, M.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S223 - S223
  • [36] Early Serum HBsAg Drop Is a Strong Predictor of HBeAg Seroconversion and HBsAg Loss to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients with Prior Nucleos(t)ide Analogue Exposure
    Chen, Qing
    Zhang, Jun
    Huang, Jianjun
    Quan, Bin
    Wu, Xiaoxin
    Deng, Shengming
    Han, Wenzheng
    MEDICAL SCIENCE MONITOR, 2019, 25 : 4665 - 4674
  • [37] NK CELL DYNAMICS IN CHRONIC HEPATITIS B PATIENTS ARE ASSOCIATED WITH HBsAg CLEARANCE AFTER COMBINATION TREATMENT WITH PEGINTERFERON ALFA-2A AND ADEFOVIR
    Stelma, F.
    de Niet, A.
    Jansen, L.
    Takkenberg, R. B.
    Janssen, H. L.
    Sinnige, M. J.
    Kootstra, N. A.
    van Leeuwen, E. M.
    Reesink, H. W.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S498 - S498
  • [38] HBsAg Profiles in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses
    Yu, Ming-Lung
    Lee, Chuan-Mo
    Chuang, Wan-Long
    Lu, Sheng-Nan
    Dai, Chia-Yen
    Huang, Jee-Fu
    Lin, Zu-Yau
    Hu, Tsung-Hui
    Chen, Chien-Hung
    Hung, Chao-Hung
    Wang, Jin-Houng
    Chen, Chi-Ling
    Kao, Jia-Horng
    Lai, Ming-Yang
    Liu, Chen-Hua
    Su, Tung-Hung
    Wu, Shun-Sheng
    Liao, Li-Ying
    Kuo, Hsing-Tao
    Chao, You-Chen
    Tung, Shui-Yi
    Yang, Sien-Sing
    Chen, Pei-Jer
    Liu, Chun-Jen
    Chen, Ding-Shinn
    JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (01): : 86 - 92
  • [39] ADD-ON PEGINTERFERON ALFA-2A SIGNIFICANTLY REDUCES HBsAg LEVELS IN HBeAg-NEGATIVE, GENOTYPE D CHRONIC HEPATITIS B PATIENTS FULLY SUPPRESSED ON NUCLEOT(S)IDE ANALOGUE TREATMENT: THE HERMES STUDY
    Lampertico, P.
    Brunetto, M. R.
    Craxi, A.
    Gaeta, G. B.
    Rizzetto, M.
    Palmieri, G.
    Colombo, M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S276 - S276
  • [40] KINETICS OF HBSAG DECLINE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B TREATED WITH PEGINTERFERON ALFA-2A ACCORDING TO GENOTYPE AND ITS ASSOCIATION WITH SUSTAINED HBSAG CLEARANCE 4 YEARS POST-TREATMENT
    Brunetto, Mourizia
    Bonino, Ferruccio
    Marcellin, Patrick
    Button, Peter
    Batrla, Richard
    HEPATOLOGY, 2008, 48 (04) : 740A - 740A
12345